These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 10431273)

  • 1. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
    Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
    J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study.
    Andersen PE; Bolstad B; Berg KJ; Justesen P; Thayssen P; Kloster YF
    Clin Radiol; 1993 Oct; 48(4):268-72. PubMed ID: 8243006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention.
    Sutton AG; Ashton VJ; Campbell PG; Price DJ; Hall JA; de Belder MA
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):346-52. PubMed ID: 12410513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate.
    Fransson SG; Stenport G; Andersson M
    Acta Radiol; 1996 Mar; 37(2):218-22. PubMed ID: 8600966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.
    Tveit K; Bolz KD; Bolstad B; Haugland T; Berg KJ; Skjaerpe T; Kloster YF
    Acta Radiol; 1994 Nov; 35(6):614-8. PubMed ID: 7946687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography.
    Palmers Y; De Greef D; Grynne BH; Smits J; Put E
    Eur J Radiol; 1993 Nov; 17(3):203-9. PubMed ID: 8293750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
    Bertrand ME; Esplugas E; Piessens J; Rasch W
    Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trial.
    Siegel EL; Rosenblum JD; Eckard DA; Leef J; Bergh J; Parsa MB; Redick ML
    Acad Radiol; 1996 Sep; 3 Suppl 3():S507-13. PubMed ID: 8883529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac hemodynamic effects of iodixanol, iopamidol, and ioxaglate following left coronary injections in anesthetized dogs.
    Morris TW; Dukovic D; Pagani E
    Acad Radiol; 1995 Jan; 2(1):33-7. PubMed ID: 9419521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in coronary angiography.
    Persson P; Liss P; Hansell P
    J Am Coll Cardiol; 2007 Apr; 49(15):1668-1669. PubMed ID: 17433962
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of low osmolality ionic (ioxaglate) versus nonionic (iopamidol) contrast media in cardiac angiography.
    Wisneski JA; Gertz EW; Dahlgren M; Muslin A
    Am J Cardiol; 1989 Feb; 63(7):489-95. PubMed ID: 2916435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
    Deray G
    J Am Coll Cardiol; 2007 Apr; 49(15):1668. PubMed ID: 17433961
    [No Abstract]   [Full Text] [Related]  

  • 16. Vectorcardiographic changes during cardioangiography with iodixanol and ioxaglate.
    Flinck A; Selin K
    Int J Cardiol; 2000; 76(2-3):173-80. PubMed ID: 11104872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
    Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
    Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic changes induced by cardiac angiography with ioxaglate: comparison with diatrizoate.
    Hirshfeld JW; Laskey W; Martin JL; Groh WC; Untereker W; Wolf GL
    J Am Coll Cardiol; 1983 Nov; 2(5):954-7. PubMed ID: 6630771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodixanol in leg phlebography: a randomized, double-blind parallel group phase III trial comparing iodixanol to ioxaglate.
    Sapoval MR; Beyssen BM; Girardot C; Musset MA; Legmann P; Brekke O; Gaux JC
    Clin Radiol; 1996 Mar; 51(3):210-3. PubMed ID: 8605753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
    Davidson CJ; Laskey WK; Hermiller JB; Harrison JK; Matthai W; Vlietstra RE; Brinker JA; Kereiakes DJ; Muhlestein JB; Lansky A; Popma JJ; Buchbinder M; Hirshfeld JW
    Circulation; 2000 May; 101(18):2172-7. PubMed ID: 10801758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.